All In Biotech

Drugs by condition

Drugs approved for acute pain

Brand-name prescription drugs and biologics whose FDA label lists acute pain as an approved use. Matched on the label phrases: "acute pain".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

11

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

4

New molecular entities and new biologics

In development

8

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for acute pain.

  • Vyscoxa (Celecoxib) · Carwin Pharm Assoc Jul 29, 2025
  • Journavx (Suzetrigine) · Vertex Pharms INC NovelBreakthrough therapyPriority reviewJan 30, 2025
  • Combogesic (Acetaminophen, Ibuprofen) · Aft Pharms US Mar 1, 2023
  • Licart (Diclofenac Epolamine) · Ibsa Inst Bio Dec 19, 2018
  • Zipsor (Diclofenac Potassium) · Cosette Jun 16, 2009

All approved drugs for acute pain, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 91 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Nonsteroidal Anti-inflammatory Drug (3)

  • Celebrex Celecoxib · Upjohn · 1998
  • Vyscoxa Celecoxib · Carwin Pharm Assoc · 2025
  • Combogesic Acetaminophen, Ibuprofen · Aft Pharms US · 2023

Sodium Channel Blocker (1)

  • Journavx Suzetrigine · Vertex Pharms INC · 2025

Class not listed in FDA's data (7)

  • Nucynta Tapentadol Hydrochloride · Collegium Pharm INC · 2008
  • Naropin Ropivacaine Hydrochloride · Fresenius Kabi USA · 1996
  • Licart Diclofenac Epolamine · Ibsa Inst Bio · 2018
  • Zipsor Diclofenac Potassium · Cosette · 2009
  • Morphine Sulfate Morphine Sulfate · Hikma · 2008
  • Morphine Sulfate Morphine Sulfate · Hikma · 2008
  • Flector Diclofenac Epolamine · Ibsa · 2007

Drugs in development for acute pain

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CebranopadolTRN-228Phase 34 trials

    Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain

  • MR-107A-02Phase 31 trial

    Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain

  • matched to VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • GRT7040Phase 21 trial

    Grünenthal GmbH · Acute Pain, Bunionectomy

  • LTG-001Phase 21 trial

    Latigo Biotherapeutics · Acute Pain, Postoperative

  • LY4515100Phase 21 trial

    Eli Lilly · Acute Pain, Molar, Molar, Third

  • SRP-001Phase 21 trial

    South Rampart Pharma, Inc. · Acute Pain, Postoperative Pain, Pain

2 discontinued brand-name drugs whose label still names it
  • Olinvyk Oliceridine
  • Apadaz Acetaminophen, Benzhydrocodone Hydrochloride

More on acute pain: recruiting trials · published research

Related in pain and anesthesia: Neuropathic pain · Osteoarthritis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.